$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What are the efficacy and functions of Vigabatrin/vigabatrin, and what are the indications?
2026-02-01 22:25:32
Check Details
莫博赛替尼/莫博替尼仿制药是否存在? How can patients choose more economical treatment options?
2026-02-01 22:25:32
Check Details
FDA approves tepotinib as companion diagnostic in mNSCLC harboring MET exon 14 skipping alterations
2026-02-01 22:25:32
Check Details
What are the results of clinical trials of zotuximab in gastric cancer?
2026-02-01 22:25:32
Check Details
Regorafenib/Sintilimab shows tolerability and mixed efficacy in MSS mCRC
2026-02-01 22:25:32
Check Details
Is 0.01% Atropine Sulfate Eye Drops suitable for children? How to use it correctly?
2026-02-01 22:25:32
Check Details
Is the targeted drug platinib the best choice for RET fusion lung cancer? Analysis of efficacy and adaptability to crowds
2026-02-01 22:25:32
Check Details
Which generation of targeted drugs does capmatinib belong to? What is the effect?
2026-02-01 22:25:32
Check Details
What are the side effects of margetuximab? Who cannot use it?
2026-02-01 22:25:32
Check Details
What are the efficacy and effects of larotinib/larlotinib? Which patients are suitable for use?
2026-02-01 22:25:32
Check Details
Selinisol plus pomalidomide/dexamethasone for the treatment of R/R myeloma
2026-02-01 22:25:32
Check Details
A major breakthrough in the treatment of epilepsy: latest price and cost analysis of the new generation of anti-epileptic drugs Vigabatrin/vigabatrin
2026-02-01 22:25:32
Check Details
1
2
...
1340
1341
1342
1343
1344
1345
1346
...
10239
10240
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
2
Revumenib: Key Considerations Before and During Treatment
3
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
4
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
5
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
6
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use
7
Dasatinib: A BCR-ABL Targeted TKI, Not Conventional Chemo
8
Obeticholic Acid (OCA): FXR Therapy in PBC and Liver Safety Limits
9
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
10
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
11
Eltrombopag: TPO-Receptor Agonist in ITP and Severe Aplastic Anemia
12
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure